Subscribe to Newsletter
Discovery & Development Drug Discovery

Biologically Driven

| 4 min read

Academia has its appeal for many; for others the real challenges are in industry. Here, IO Biotech CEO Mai-Britt Zocca discusses her own motivations.

Discovery & Development Drug Delivery

Bladder Runner

| Rob Coker | 2 min read

Self-propelled nanoparticles can reduce tumors in the bladder by 90 percent

Discovery & Development Clinical Trials

Remote Research

| Rob Coker

A host of pharma industry experts discuss the increasing use of digital technology in decentralized clinical trials.

Business & Regulation Business Practice

Drug Price Negotiations, Counteroffers, and Lawsuits

| Stephanie Vine | 4 min read

The US Inflation Reduction Act continues to generate controversy as drugmakers make counteroffers.

Manufacture Advanced Medicine

Cell and Gene Therapies: Live at Phacilitate with Delara Motlagh, Head of Global Cell Therapy, Catalent

Discussing the trends in cell and gene therapeutics, with Delara Motlagh, Head of Global Cell Therapy, Catalent

Business & Regulation Digital Technologies

Dr. Mario and the Role of Video Games in Depression

| Stephanie Vine | 12 min read

How a study involving Super Mario Odyssey and depression captured imaginations.

Manufacture Advanced Medicine

Cell and Gene Therapies: Live at Phacilitate with George Eastwood, Board Member, Emily Whitehead Foundation

Discussing the trends in cell and gene therapeutics, with George Eastwood, Board Member, Emily Whitehead Foundation

Business & Regulation Standards & Regulation

The Device Is Right

| Hilde Viroux | 5 min read

Three regulatory pathways for drug–device combinations – and why early action is key.

Manufacture Advanced Medicine

Cell and Gene Therapies: Live at Phacilitate with Stella Vnook, CEO, Likarda

Discussing the trends in cell and gene therapeutics, with Stella Vnook, CEO, Likarda

Discovery & Development Drug Discovery

Cancer and the Combination Approach

| Liz Henderson | 3 min read

Oncology is a tricky sector in which to innovate, but we can start by optimizing existing combination approaches

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register